Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Maj 2022

Genmab — Maj 2022

Planlagt Fastgjort Låst Flyttet Genmab
1.3k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • BulderB Offline
    BulderB Offline
    Bulder
    wrote on sidst redigeret af
    #1237

    Kan måske tolkes som at vi ligger på den rigtige side af 35,2%.

    1 Reply Last reply
    0
    • BulderB Offline
      BulderB Offline
      Bulder
      wrote on sidst redigeret af
      #1238

      Vi kan muligvis ende der, at epco har lidt lavere CR, men en mere syg population.

      1 Reply Last reply
      0
      • BulderB Offline
        BulderB Offline
        Bulder
        wrote on sidst redigeret af
        #1239

        I hvert fald har epco ingen grad 4 CRS, i modsætning til glofi.

        1 Reply Last reply
        0
        • SolsenS Offline
          SolsenS Offline
          Solsen
          wrote on sidst redigeret af
          #1240

          CarT data i MM er voldsomt gode. Men der skal større forsøg og længere opfølgning til https://twitter.com/jacobplieth/status/1529930376432349184?s=21&t=z8qiRvo9t1Avj0dljk2o9A

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #1241

            Dara plus teclistamab kombien var da lige så god, så vidt jeg husker.

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #1242

              Just a moment...

              favicon

              (www.onclive.com)

              1 Reply Last reply
              0
              • BulderB Offline
                BulderB Offline
                Bulder
                wrote on sidst redigeret af
                #1243

                Men det forspring har vi måske indhentet på torsdag.

                1 Reply Last reply
                0
                • SolsenS Offline
                  SolsenS Offline
                  Solsen
                  wrote on sidst redigeret af
                  #1244

                  Jeg tvivlet også stadig på CarT’s konkurrenceevne. Og CD19 er et tvivlsomt target mht SAE. Så rigtigt bulder så er tec+dara rigtig spændende.

                  1 Reply Last reply
                  0
                  • J Offline
                    J Offline
                    JKY_VH
                    wrote on sidst redigeret af
                    #1245

                    men muligheden er der, så JnJ har al mulig interesse i at gå med i udviklingen af CD38

                    1 Reply Last reply
                    0
                    • B Offline
                      B Offline
                      bibob
                      wrote on sidst redigeret af
                      #1246

                      Også en god nyhed fra ASCO fra JnJ. https://www.fiercebiotech.com/biotech/asco-jjs-multiple-myeloma-toolkit-expands-bispecifics-data?utm_source=email&utm_medium=email&utm_campaign=LS-NL-FierceBiotech&oly_enc_id=6900G6464778A3A

                      1 Reply Last reply
                      0
                      • B Offline
                        B Offline
                        bibob
                        wrote on sidst redigeret af
                        #1247

                        Just a moment...

                        favicon

                        (www.fiercebiotech.com)

                        1 Reply Last reply
                        0
                        • B Offline
                          B Offline
                          bibob
                          wrote on sidst redigeret af
                          #1248

                          Will J&J buy Boston Scientific. ?? https://www.massdevice.com/will-johnson-johnson-buy-boston-scientific/

                          1 Reply Last reply
                          0
                          • BulderB Offline
                            BulderB Offline
                            Bulder
                            wrote on sidst redigeret af
                            #1249

                            Carvykti: “We’ve taken a different point of view and said […] let’s treat those patients who are treatment-naïve,” Widgust said. “I think we’re saying let’s go right to the newly diagnosed setting.”

                            1 Reply Last reply
                            0
                            • BulderB Offline
                              BulderB Offline
                              Bulder
                              wrote on sidst redigeret af
                              #1250

                              Just a moment...

                              favicon

                              (www.fiercepharma.com)

                              1 Reply Last reply
                              0
                              • B Offline
                                B Offline
                                bibob
                                wrote on sidst redigeret af
                                #1251

                                Just a moment...

                                favicon

                                (www.fiercepharma.com)

                                1 Reply Last reply
                                0
                                • J Offline
                                  J Offline
                                  JKY_VH
                                  wrote on sidst redigeret af
                                  #1252

                                  Så lad os deltage i "Langers" fest https://ugebrev.dk/flashnews/langers-skarpe-kaempe-aktiefest-forude-oeus-investeringsfond-oeger-i-tech-og-biotech/?utm_source=Dagens+nyheder&utm_campaign=225cda3853-Dagens+Nyheder+-+Investering+Aften&utm_medium=email&utm_term=0_854578a5a7-225cda3853-108502749&mc_cid=225cda3853&mc_eid=398e30fe9c

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    peter12
                                    wrote on sidst redigeret af
                                    #1253

                                    Salgstallet for april var åbenbart -2,4% https://www.jyskebank.dk/finansnyt/morgennyt/90931419-a728-4a3d-a275-c4c516cc51ef

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      ProinvestorNEWS
                                      wrote on sidst redigeret af
                                      #1254

                                      God morgen. 🙂

                                      1 Reply Last reply
                                      0
                                      • Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktør
                                        wrote on sidst redigeret af
                                        #1255

                                        God morgen. 🙂

                                        1 Reply Last reply
                                        0
                                        • S Offline
                                          S Offline
                                          Stroka
                                          wrote on sidst redigeret af
                                          #1256

                                          God morgen. 🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper